Arsenic represents a ubiquitous environmental contaminant with adult toxicity in humans and developmental toxicity in laboratory animals. While published reports indicate differential strain sensitivity to induction of NTDs in animal models following prenatal arsenic exposure remain unclear. As such, the need exists to understand the mechanisms underlying interactions between arsenic and maternal/embryonic genotype during development, as well as understand the mechanisms by which suspected human developmental toxicants, such as arsenic, interact with critical aspects of embryonic development. This is particularly true regarding precursor cell populations which populate the early embryo and differentiate during early organogenesis. The proposed research program will investigate the developmental hazards associated with arsenic exposure in a genetically sensitive mouse model in which the folate binding proteins, Folbp1 or Folb2 have been inactivated. Preliminary analysis indicates that animals lacking Flobps demonstrate an increased prenatal risk for arsenic-induced NTDs. The hypothesis to be examined in the present application is that an abnormal folate binding protein genotype increases the risk for arsenic-induced NTDs, the resulting phenotype of which is associated with alterations in cranial neural crest gene expression (i.e. neural crest function). Through breeding of Folbp knockout mice to Wnt1-cre/LoxP mice, a novel """"""""composite"""""""" mouse model will be generated which is """"""""genetically sensitive"""""""" to arsenic induction of NTDs and in which the neural crest are indelibly (genetically) marked. Such a mouse model will enable analysis of the effects of arsenic on neural crest formation, migration and proliferation under conditions of differing Folbp genotypes (Specific Aim 1). In addition, the application of laser capture microdissection (of neural crest cells) and DNA microarray technologies to this animal model will facilitate generation of isolated neural crest """"""""gene expression profiles"""""""" during neural tube morphogenesis and under conditions of arsenic-induced NTDs among embryos of differing Folbp genotypes (Specific Aim 2).

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21ES011775-02
Application #
6629411
Study Section
Special Emphasis Panel (ZES1-EBJ-D (DT))
Program Officer
Heindel, Jerrold
Project Start
2002-03-15
Project End
2006-01-31
Budget Start
2003-02-01
Budget End
2006-01-31
Support Year
2
Fiscal Year
2003
Total Cost
$131,579
Indirect Cost
Name
University of Louisville
Department
Dentistry
Type
Schools of Dentistry
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Singh, Saurabh; Greene, Robert M; Pisano, M Michele (2010) Arsenate-induced apoptosis in murine embryonic maxillary mesenchymal cells via mitochondrial-mediated oxidative injury. Birth Defects Res A Clin Mol Teratol 88:25-34
Bhattacherjee, Vasker; Mukhopadhyay, Partha; Singh, Saurabh et al. (2007) Neural crest and mesoderm lineage-dependent gene expression in orofacial development. Differentiation 75:463-77
Singh, Saurabh; Yin, Xiaolong; Pisano, M Michele et al. (2007) Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development. Birth Defects Res A Clin Mol Teratol 79:35-44
Mukhopadhyay, P; Singh, S; Greene, R M et al. (2006) Molecular fingerprinting of BMP2- and BMP4-treated embryonic maxillary mesenchymal cells. Orthod Craniofac Res 9:93-110
Mukhopadhyay, Partha; Greene, Robert M; Pisano, M Michele (2006) Expression profiling of transforming growth factor beta superfamily genes in developing orofacial tissue. Birth Defects Res A Clin Mol Teratol 76:528-43
Greene, Robert M; Pisano, M Michele (2005) Recent advances in understanding transforming growth factor beta regulation of orofacial development. Hum Exp Toxicol 24:1-12
Spiegelstein, Ofer; Gould, Amy; Wlodarczyk, Bogdan et al. (2005) Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies. Toxicol Appl Pharmacol 203:18-26
Mukhopadhyay, Partha; Greene, Robert M; Zacharias, Wolfgang et al. (2004) Developmental gene expression profiling of mammalian, fetal orofacial tissue. Birth Defects Res A Clin Mol Teratol 70:912-26
Greene, Robert M; Pisano, M Michele (2004) Perspectives on growth factors and orofacial development. Curr Pharm Des 10:2701-17
Spiegelstein, Ofer; Lu, Xiufen; Le, X Chris et al. (2003) Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. Toxicol Lett 145:167-74